Study compares weight loss with semaglutide versus liraglutide after one yearThe study also identifies factors associated with a clinically meaningful (≥ 10%) weight reduction at one year. NEW PRODUCT: NordimetGet the info you need on this new product, part of our drug news roundup for September. NEW DRUG: Vaxchora: oral cholera vaccine Get the info you need on this new product, part of our drug news roundup for September. NEW DRUG: Quillivant ER for ADHD Get the info you need on this new product, part of our drug news roundup for September. Can the shingles vaccine really delay dementia onset? Study says yes, but not everyone is convinced. NEW DRUG: Awiqli: first once-weekly basal insulin Get the info you need on this new product, part of our drug news roundup for September. NEW DRUG: Apretude: long-acting injection for HIV PrEP Get the info you need on this new product, part of our drug news roundup for September. Should renin-angiotensin system inhibitors be discontinued before surgery? Study examines the effects of continuation versus discontinuation of ACEIs and ARBs before major noncardiac surgery. Two new studies investigate the risk of suicidality with GLP-1 receptor agonists These studies suggest that semaglutide and liraglutide are not linked with suicidality, but questions still remain. Risks of prolonged or incident diabetic ketoacidosis despite stopping SGLT2 inhibitor treatment Health Canada recommends stopping treatment with SGLT2 inhibitors at least three days before surgery or other invasive procedures requiring prolonged fasting. First Previous 11 12 13 14 15 Next Last
